Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.
Quantifying the early stages of remyelination following cuprizone-induced demyelination.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
GlaxoSmithKline Protocol Summaries: Firategrast
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Sex differences in autoimmune diseases.
Immunopathogenesis of neuromyelitis optica.
Testosterone treatment in multiple sclerosis: a pilot study.
Pregnancy and multiple sclerosis.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review.
Best practice in the use of natalizumab in multiple sclerosis.
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
The neuroendocrine axis in patients with multiple sclerosis.
The relevance of animal models in multiple sclerosis research.
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.

Pages